JILIN CHANGLONG8049.HKValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Richly Valued” zone.
As of Oct 16, 2026, JILIN CHANGLONG (8049.HK) trades at a P/E of 5.54x, P/B of 0.66x, P/S of 1.35x, and a dividend yield of 0.00%.
Longitudinal percentile comparison: P/E sits at the 76th percentile over the trailing 10Y window (vs. 55th percentile over 3Y); P/B sits at the 77th percentile over the trailing 10Y window (vs. 81st percentile over 3Y); P/S sits at the 93rd percentile over the trailing 10Y window (vs. 93rd percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 10th percentile within its industry and the 21st percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 0.00%; its historical percentile over the trailing long-term window is still accumulating data.
The P/E and P/B long-window percentiles differ by only 1.0 points, pointing to a consistent valuation read across both metrics. Relative to industry peers, its P/E shows a deeper discount than it does against the broader market. Shareholder returns here are driven almost entirely by cash dividends, with minimal contribution from buybacks. JILIN CHANGLONG operates in the Pharmaceutical Chemistry sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: HKG: 8049 · SEHK: 8049 · 8049
Want the full picture on whether JILIN CHANGLONG (8049.HK) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 5.54 | ||||||
| P/B (MRQ) | 0.66 | ||||||
| P/S (TTM) | 1.35 | ||||||
| Dividend Yield | 0.00% | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback + Div Yield | 0.00% | 0 | 0 | 0 | 0 | 0 | 0 |